Sunstone på vej med ny life science fond på 150 mio. Euro

Første closing ventes til sommer. Salget af Prexton til Lundbeck har styrket Sunstones investeringscase.

Managing partner i Sunstone Capital, Peter Benson | Photo: Sunstone Capital / PR

Sunstone Capital er gået i gang med at rejse kapital til en ny fjerde life science fond. Målet er 150 mio. euro.  Sunstone Capital håber at kunne lave en first closing på den nye fond til sommer og at kunne lukke den helt for nye investorer i begyndelsen af 2019.

”Vi har haft sonderinger til vores nuværende investorer og til enkelte nye investorer, og det ser fornuftigt ud”, siger managing partner i Sunstone Capital, Peter Benson.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

The ESG market is controlled by a few big investors

Finland's largest investor holds 62 percent of shares of multi-trillion ETFs offered by iShares and 64 percent of Xtrackers' equivalent offering. Having a few investors dominating ownership in this way is not good for the vehicles' liquidity and could be a big challenge facing the sector.

"We continue to see further growth in our Nordic book of business"

DECEMBER SERIES: What were the most important developments at some of the global asset managers present on the Nordic market in 2021, and what are their expectations for the coming year? AMWatch's December series is kicked off by Head of Nordics at State Street Global Advisors, Arnaud Bruyneel. 

Latest news


Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch